Fluo Labs is a premarket clinical-stage medical device company that is pioneering a new category in nasal allergy care. Our OTC device will use light therapy to deliver drug-free relief of seasonal allergy symptoms. We are preparing for our final clinical trial during the upcoming fall ragweed season and plan to submit a De Novo petition to the FDA later in 2021. Our breakthrough technology is currently being developed to help improve the symptoms and quality of life of millions of allergy sufferers throughout the world.